Search results for "Kidney Function"
Biomarkers may predict which medications are effective for patients hospitalized for COVID-19
Two studies looked at biomarkers that could be used to identify high-risk hospital patients who would likely benefit from medications for COVID-19, while another recent analysis provided reassuring data on the aftereffects of acute kidney injury during COVID-19 hospitalization.
https://acphospitalist.acponline.org/archives/2024/02/28/free/biomarkers-may-predict-which-medications-are-effective-for-patients-hospitalized-for-covid-19.htm
28 Feb 2024
Acute kidney injury
Documenting acute kidney injury frequently requires assessing the trajectory of a patient's creatinine levels.
https://acphospitalist.acponline.org/archives/2024/01/17/acute-kidney-injury.htm
17 Jan 2024
Acute kidney injury had only small association with worsening of chronic kidney disease
After adjustment for patient characteristics, such as prehospitalization estimated glomerular filtration rate (eGFR) slope and proteinuria, an episode of acute kidney injury in the hospital did not consistently predict subsequent decline in eGFR.
https://acphospitalist.acponline.org/archives/2023/07/12/acute-kidney-injury-had-only-a-small-association-with-worsening-of-chronic-kidney-disease.htm
12 Jul 2023
Continuous vs. intermittent meropenem administration did not improve outcomes in sepsis
A composite outcome of mortality and new antimicrobial resistance did not differ by whether critically ill patients received an equal dose of the beta-lactam antibiotic continuously or intermittently, an international randomized trial found.
https://acphospitalist.acponline.org/archives/2023/06/21/continuous-vs-intermittent-meropenem-administration-did-not-improve-outcomes-in-sepsis.htm
21 Jun 2023
Antibiotic regimens differ in associated risk of AKI in critically ill patients
Vancomycin and piperacillin/tazobactam were associated with a higher risk of acute kidney injury (AKI) than either vancomycin and cefepime or vancomycin and meropenem in ICU patients, particularly at longer durations and in those with normal kidney function on admission.
https://acphospitalist.acponline.org/archives/2023/04/19/antibiotic-regimens-differ-in-associated-risk-of-aki-in-critically-ill-patients.htm
19 Apr 2023
Early invasive treatment for NSTEMI may not benefit patients with chronic kidney disease
Early treatment for non-ST-segment elevation myocardial infarction (NSTEMI) was associated with a 30% improvement in survival compared to delayed treatment, but the association was attenuated as renal function declined, a retrospective study in Israel found.
https://acphospitalist.acponline.org/archives/2022/10/05/early-invasive-treatment-for-nstemi-may-not-benefit-patients-with-chronic-kidney-disease.htm
5 Oct 2022
Acetazolamide improved decongestion in acute decompensated heart failure
A randomized trial found that the drug, already approved for other indications, achieved successful decongestion within three days in 42.2% of acute decompensated heart failure patients, compared to 30.5% of those on placebo.
https://acphospitalist.acponline.org/archives/2022/08/31/acetazolamide-improved-decongestion-in-acute-decompensated-heart-failure.htm
31 Aug 2022
Cystatin C improves accuracy in calculations of Black patients' kidney function
Equations to estimate glomerular filtration rate more accurately predict risk of kidney failure and mortality in Black patients if they include both creatinine and cystatin C, but not race, according to a new retrospective study.
https://acphospitalist.acponline.org/archives/2022/06/15/cystatin-c-improves-accuracy-in-calculations-of-black-patients-kidney-function.htm
15 Jun 2022
When your patient is on dialysis
A nephrologist ran down the initial steps hospitalists should take after admitting a long-term dialysis patient during a lecture at Internal Medicine Meeting 2022.
https://acphospitalist.acponline.org/archives/2022/05/11/when-your-patient-is-on-dialysis.htm
11 May 2022
Advance care planning assessed, therapeutic heparin debated in recent COVID-19 articles
Along with an analysis of the pre-existing conditions of patients who died of COVID-19 and a point/counterpoint on use of heparin in ward patients, the latest inpatient COVID-19 research included negative trials of losartan and a potential monoclonal antibody.
https://acphospitalist.acponline.org/archives/2022/03/23/free/advance-care-planning-assessed-therapeutic-heparin-debated-in-recent-covid-19-articles.htm
23 Mar 2022